MIAMI--(BUSINESS WIRE)--A report by Heru Inc., the innovative vision diagnostics and augmentation leader, indicates that visual field test results from its wearable platform, re:Vive by Heru, are ...
The COVID-19 pandemic made it clear that we need novel solutions for monitoring patients with chronic diseases such as glaucoma. One area that is particularly ripe for disruption is perimetry testing.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback